Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
Cancer Discovery
|
July 4, 2019
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
Mautin Hundeyin, Emma Kurz, Ankita Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer
Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Cancer Research
|
September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Chloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer
|
June 30, 2025
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer
Laura Antonucci, Na Li, Angeles Duran, et al.
Nature Cancer
|
January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Jason M Link, Jennifer R Eng, Carl Pelz, et al.
Nature Chemical Biology
|
May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Christian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Nature
|
April 15, 2021
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
Emiliano Maiani, Giacomo Milletti, Francesca Nazio, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway
Motoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2024
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
George Zogopoulos, Ido Haimi, Shenin A Sanoba, et al.
The Journal of Clinical Investigation
|
May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
Cancer Discovery
|
July 4, 2019
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
Mautin Hundeyin, Emma Kurz, Ankita Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer
Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Cancer Research
|
September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
Chloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Nature Cancer
|
June 30, 2025
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer
Laura Antonucci, Na Li, Angeles Duran, et al.
Nature Cancer
|
January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Jason M Link, Jennifer R Eng, Carl Pelz, et al.
Nature Chemical Biology
|
May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Christian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Nature
|
April 15, 2021
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity
Emiliano Maiani, Giacomo Milletti, Francesca Nazio, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway
Motoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2024
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
George Zogopoulos, Ido Haimi, Shenin A Sanoba, et al.
The Journal of Clinical Investigation
|
May 16, 2017
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar, Abbey Perl, Rita Tohme, et al.
Page
of 20